Document is current
Any future updates will be listed below
-
Authors
Muralidhar, Anusha
Gamat-Huber, Melissa
Vakkalanka, Sita
McNeel, Douglas G https://orcid.org/0000-0003-1471-6723
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04989946 at ClinicalTrials.govnct04989946 at ClinicalTrials.govDocuments that mention this clinical trial
1478 Phase 1/2 trial of androgen deprivation, with or without pTVG-AR, and with or without nivolumab, in patients with newly diagnosed, high-risk prostate cancer
https://doi.org/10.1136/jitc-2024-sitc2024.1478
Androgen deprivation, androgen receptor-targeted vaccination, and nivolumab in patients with high-risk localized prostate cancer
https://doi.org/10.1136/jitc-2025-013790
Sequence of androgen receptor-targeted vaccination with androgen deprivation therapy affects anti-prostate tumor efficacy
https://doi.org/10.1136/jitc-2024-008848
nct04989946 at ClinicalTrials.govDocuments that mention this clinical trial
1478 Phase 1/2 trial of androgen deprivation, with or without pTVG-AR, and with or without nivolumab, in patients with newly diagnosed, high-risk prostate cancer
https://doi.org/10.1136/jitc-2024-sitc2024.1478
Androgen deprivation, androgen receptor-targeted vaccination, and nivolumab in patients with high-risk localized prostate cancer
https://doi.org/10.1136/jitc-2025-013790
Sequence of androgen receptor-targeted vaccination with androgen deprivation therapy affects anti-prostate tumor efficacy
https://doi.org/10.1136/jitc-2024-008848
Documents that mention this clinical trial
1478 Phase 1/2 trial of androgen deprivation, with or without pTVG-AR, and with or without nivolumab, in patients with newly diagnosed, high-risk prostate cancer
https://doi.org/10.1136/jitc-2024-sitc2024.1478
Androgen deprivation, androgen receptor-targeted vaccination, and nivolumab in patients with high-risk localized prostate cancer
https://doi.org/10.1136/jitc-2025-013790
Sequence of androgen receptor-targeted vaccination with androgen deprivation therapy affects anti-prostate tumor efficacy
https://doi.org/10.1136/jitc-2024-008848
-
Funding
Funding for this research was provided by:
NIH National Cancer Institute (P50 CA269011)
- License Information
